The chief of Toxicology has been responsible for filing 18 IND applications and 2NDAs in the US. He is a recognized expert with more than 25 years of experience in preclinical, clinical research and commercialization of new drugs.

The chief of pharmacology is an expert in oncology, with an impressive track record of strong academic research and industrial drug development achievement. He has been engaged in research and development and management of new drugs in prestige institute and biopharmaceutical industry in the US for more than 20 years, focusing on efficacy evaluation of new drugs and safety evaluation of targets.

The chief of clinical translation has rich clinical and medical experience in oncology . He has been engaged in clinical translation research and development for more than 20 years, involved in 30+ IND applications and 3 NDAs. He has expertise in managing the entire process of clinical development and risk control.

The chief of business development has been engaged in corporate development for more than 25 years. He is highly experienced in global business development, partnering and commercialization, with strong expertise in financing transaction,negotiation and post-investment management. He has been responsible for over 20 major corporate asset acquisition/licensing transactions, with transaction value over $1.35 billion.